Regulation of the renal microcirculation by ryanodine receptors and calcium-induced calcium release

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 1, 2009, Pages 40-49

  Arendshorst, William J ^a,b   Thai, Tiffany L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine diphosphate ribosyl cyclase; Afferent arteriole; Cyclic adenosine diphosphate ribose; Nicotinic acid adenine dinucleotide phosphate; Sarcoplasmic reticulum; Vascular smooth muscle

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; ANGIOTENSIN II; CALCIUM; CD38 ANTIGEN; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; INOSITOL TRISPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; NORADRENALIN; RYANODINE RECEPTOR; SUPEROXIDE;

ARTERIOLE; ATTENUATION; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CULTURE; CELL INTERACTION; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULUS; IN VIVO STUDY; JUXTAGLOMERULAR CELL; KIDNEY; KIDNEY ARTERY; KIDNEY FUNCTION; MESANGIUM CELL; MICROCIRCULATION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SARCOPLASMIC RETICULUM; SECOND MESSENGER; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ADP-RIBOSYL CYCLASE; ANIMALS; CALCIUM; CALCIUM CHANNELS; HUMANS; MICROCIRCULATION; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; RENAL CIRCULATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SECOND MESSENGER SYSTEMS;

EID: 58149269148     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32831cf5bd     Document Type: Review

References (119)

1. Endo M. Mechanisms of calcium release from the sarcoplasmic reticulum in skeletal muscle. Adv Exp Med Biol 2005; 565:233-247.
2. Bellinger AM, Mongillo M, Marks AR. Stressed out: the skeletal muscle ryanodine receptor as a target of stress. J Clin Invest 2008; 118:445-453.
3. Bers DM. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 2004; 37:417-429.
4. Zalk R, Lehnart SE, Marks AR. Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem 2007; 76:367-385.
5. Meissner G. Molecular regulation of cardiac ryanodine receptor ion channel. Cell Calcium 2004; 35:621-628.
6. Chini EN, Chini CC, Barata da SH, Zielinska W. The cyclic-ADP-ribose signaling pathway in human myometrium. Arch Biochem Biophys 2002; 407:152-159.
7. Deshpande DA, White TA, Dogan S, et al. CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2005; 288:L773-L788.
8. Fukushi Y, Kato I, Takasawa S, et al. Identification of cyclic ADP-ribosedependent mechanisms in pancreatic muscarinic Ca2+ signaling using CD38 knockout mice. J Biol Chem 2001; 276:649-655.
9. Higashida H, Salmina AB, Olovyannikova RY, et al. Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem Int 2007;51:192-199.
10. Berridge MJ. Unlocking the secrets of cell signaling. Annu Rev Physiol 2005; 67:1-21.
11. lino M. Family affairs of intracellular Ca2+-release channels. J Physiol 2002; 542:667.
12. Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev 2002; 82:893-922.
13. Sutko JL, Airey JA. Ryanodine receptor Ca2+ release channels: does diversity in form equal diversity in function? Physiol Rev 1996; 76:1027-1071.
14. Itoh T, Kuriyama H, Suzuki H. Excitation-contraction coupling in smooth muscle cells of the guinea-pig mesenteric artery. J Physiol 1981; 321:513-535.
15. Meissner G. Regulation of mammalian ryanodine receptors. Front Biosci 2002; 7:d2072-d2080.
16. Yang XR, Lin MJ, Yip KP, et al. Multiple ryanodine receptor subtypes and heterogeneous ryanodine receptor-gated Ca2+ stores in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2005; 289:L338-L348.
17. Lohn M, Jessner W, Furstenau M, et al. Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res 2001; 89:1051-1057.
18. Ledoux J, Werner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 2006; 21:69-78.
19. Thorneloe KS, Nelson MT. Ion channels in smooth muscle: regulators of intracellular calcium and contractility. Can J Physiol Pharmacol 2005; 83:215-242.
20. Neylon CB, Richards SM, Larsen MA, et al. Multiple types of ryanodine receptor/Ca2+ release channels are expressed in vascular smooth muscle. Biochem Biophys Res Commun 1995; 215:814-821.
21. 2+ from lysosomal vesicles.
22. Yusufi AN, Cheng J, Thompson MA, et al. Differential mechanisms of Ca2+ release from vascular smooth muscle cell microsomes. Exp Biol Med (Maywood) 2002; 227:36-44.
23. Evans AM, Wyatt CN, Kinnear NP, et al. Pyridine nucleotides and calcium signalling in arterial smooth muscle: from cell physiology to pharmacology. Pharmacol Ther 2005; 107:286-313.
24. Lee HC. Multiplicity of Ca2+ messengers and Ca2+ stores: a perspective from cyclic ADP-ribose and NAADP. Curr Mol Med 2004; 4:227-237.
25. Lee HC. Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol 2001; 41:317-345.
26. Guse AH. Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR). FEES J 2005; 272:4590-4597.
27. Wang YX, Zheng YM, Mei QB, et al. FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. Am J Physiol Cell Physiol 2004; 286:C538-C546.
28. Zhang AY, Li PL. Vascular physiology of a Ca2+ mobilizing second messenger - cyclic ADP-ribose. J Cell Mol Med 2006; 10:407-422.
29. Li PL, Tang WX, Valdivia HH, et al. cADP-ribose activates reconstituted ryanodine receptors from coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol 2001; 280:H208-H215.
30. Yamasaki M, Churchill GC, Galione A. Calcium signalling by nicotinic acid adenine dinucleotide phosphate (NAADP). FEBS J 2005; 272:4598-4606.
31. 2+ release channel as a NAADP receptor.
32. Zhang F, Zhang G, Zhang AY, et al. Production of NAADP and its role in Ca2+ mobilization associated with lysosomes in coronary arterial myocytes. Am J Physiol Heart Circ Physiol 2006; 291 :H274-H282.
33. Chini EN, Klener P Jr, Beers KW, et al. Cyclic ADP-ribose metabolism in rat kidney: high capacity for synthesis in glomeruli. Kidney Internat 1997; 51:1500-1506.
34. Yusufi AN, Cheng J, Thompson MA, et al. cADP-ribose/ryanodine channel/Ca2+-release signal transduction pathway in mesangial cells. Am J Physiol Renal Physiol 2001; 281:F91-F102.
35. Fellner SK, Arendshorst WJ. Angiotensin II, reactive oxygen species and Ca2+ signaling in afferent arterioles. Am J Physiol Renal Physiol 2005; 289:F1012-F1019.
36. 2+ increases by NAD(P)H oxidases and increases in superoxide anion in isolated afferent arterioles.
37. Higashida H. ADP-ribosyl cyclase coupled with receptors via G proteins. FEBS Lett 1997; 418:355-356.
38. de Toledo FG, Cheng J, Dousa TP. Retinoic acid and triiodothyronine stimulate ADP-ribosyl cyclase activity in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1997; 238:847-850.
39. Chini EN, de Toledo FG, Thompson MA, Dousa TP. Effect of estrogen upon cyclic ADP ribose metabolism: beta-estradiol stimulates ADP ribosyl cyclase in rat uterus. Proc Natl Acad Sci U S A 1997; 94:5872-5876.
40. de Toledo FG, Cheng J, Liang M, et al. ADP-ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation. Circ Res 2000; 86:1153-1159.
41. McCarthy TV, Datar S, Mackrill JJ. Activation of ryanodine receptor/Ca2+ release channels downregulates CD38 in the Namalwa B lymphoma. FEBS Lett 2003; 554:133-137.
42. • Kim SY, Gul R, Rah SY, et al. Molecular mechanism of ADP-ribosyl cyclase activation in angiotensin II signaling in murine mesangial cells. Am J Physiol Renal Physiol 2008; 294:F982-F989. This recent report examines ADPR cyclase in cultured mesangial cells, extending the pioneering work of Dousa, Grande and colleagues. Current results suggest PI3K, PLC, and tyrosine phosphorylation are involved in chronic activation of ADPR cyclase by Ang II, implicating a signaling pathway distinct from NAD(P)H oxidase.
43. Cheng J, Yusufi AN, Thompson MA, et al. Nicotinic acid adenine dinucleotide phosphate: a new Ca2+ releasing agent in kidney. J Am Soc Nephrol 2001; 12:54-60.
44. Yusufi AN, Cheng J, Thompson MA, et al. Nicotinic acid-adenine dinucleotide phosphate (NAADP) elicits specific microsomal Ca2+ release from mammalian cells. Biochem J 2001; 353:531-536.
45. Malavasi F, Deaglio S, Funaro A, et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008; 88:841-886.
46. Mitsui-Saito M, Kato I, Takasawa S, et al. CD38 gene disruption inhibits the contraction induced by alpha-adrenoceptor stimulation in mouse aorta. J Vet Med Sci 2003; 65:1325-1330.
47. Fellner SK, Arendshorst WJ. Ryanodine receptor and capacitative Ca2+ entry in fresh preglomerular vascular smooth muscle cells. Kidney Int 2000; 58:1686-1694.
48. Li N, Teggatz EG, Li PL, et al. Formation and actions of cyclic ADP-ribose in renal microvessels. Microvasc Res 2000; 60:149-159.
49. Teggatz EG, Zhang G, Zhang AY, et al. Role of cyclic ADP-ribose in Ca2+- induced Ca2+ release and vasoconstriction in small renal arteries. Microvasc Res 2005; 70:65-75.
50. Bagnis C, Deray G, Dubois M, et al. Comparative acute nephrotoxicity of FK- 506 and ciclosporin in an isolated in situ autoperfused rat kidney model. Am J Nephrol 1997; 17:17-24.
51. •• Thai TL, Fellner SK, Arendshorst WJ. ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonistinduced renal vasoconstriction in vivo. Am J Physiol Renal Physiol 2007; 293:F1107-F1114. This paper is the first to document a role of ADPR cyclase and RyR in a physiological process in vivo. The results reveal a tonic action of this system in producing renal vasoconstriction under basal conditions of euvolemia and also in mediating acute GPCR (Ang II and norepinephrine)-induced renal vasoconstriction in a rat kidney.
52. Bultynck G, De SP, Weidema AF, et al. Effects of the immunosuppressant FK506 on intracellular Ca2+ release and Ca2+ accumulation mechanisms. J Physiol 2000; 525:681-693.
53. Rostaing L, Tran-Van T, Cisterne JM, et al. Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients. Transplant Proc 1998; 30:1282-1284.
54. Nielsen FT, Ottosen P, Starklint H, Dieperink H. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat. Nephrol Dial Transplant 2003; 18:491-496.
55. Collins JH. Sequence analysis of the ryanodine receptor: possible association with a 12K, FK506-binding immunophilin/protein kinase C inhibitor. Biochem Biophys Res Commun 1991; 178:1288-1290.
56. Mayrleitner M, Timerman AP, Wiederrecht G, Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. Cell Calcium 1994; 15:99-108.
57. Balasubramanian L, Ahmed A, Lo CM, et al. Integrin-mediated mechanotransduction in renal vascular smooth muscle cells: activation of calcium sparks. Am J Physiol Regul Integr Comp Physiol 2007; 293:R1586-R1594.
58. Chan WL, Holstein-Rathlou NH, Yip KP. Integrin mobilizes intracellular Ca2+ in renal vascular smooth muscle cells. Am J Physiol Cell Physiol 2001; 280:C593-C603.
59. Umesh A, Thompson MA, Chini EN, et al. Integrin ligands mobilize Ca2+ from ryanodine receptor-gated stores and rysosome-related acidic organelles in pulmonary arterial smooth muscle cells. J Biol Chem 2006; 281:34312-34323.
60. Loutzenhiser RD, Wang X, Breaks J, Loutzenhiser K. Determinants of the rapid kinetics of the afferent arteriolar myogenic response: Role of stretchinduced renelas of intracellular calcium stores (Abstract). J Am Soc Nephrol 2006; 17:716A.
61. Ganitkevich VY, Isenberg G. Efficacy of peak Ca2+ currents (ICa) as trigger of sarcoplasmic reticulum Ca2+ release in myocytes from the guinea-pig coronary artery. J Physiol 1995; 484:287-306.
62. Geiger J, Zou AP, Campbell WB, Li PL. Inhibition of cADP-ribose formation produces vasodilation in bovine coronary arteries. Hypertension 2000; 35:397-402.
63. Kamishima T, Mc Carron JG. Regulation of the cytosolic Ca2+ concentration by Ca2+ stores in single smooth muscle cells from rat cerebral arteries. J Physiol 1997; 501:497-508.
64. 2+ entry can activate RyR- mediated CICR in freshly isolated renal afferent arterioles.
65. Takenaka T, Ohno Y, Hayashi K, et al. Governance of arteriolar oscillation by ryanodine receptors. Am J Physiol Regul Integr Comp Physiol 2003; 285:R125-R131.
66. Zhang Q, Cao C, Zhang Z, et al. Membrane current oscillations in descending vasa recta pericytes. Am J Physiol Renal Physiol 2008; 294:F656-F666.
67. Gordienko DV, Bolton TB. Crosstalk between ryanodine receptors and IP(3) receptors as a factor shaping spontaneous Ca(2+)-release events in rabbit portal vein myocytes. J Physiol 2002; 542:743-762.
68. Fellner SK, Arendshorst WJ. Angiotensin II Ca2+ signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways. Am J Physiol Renal Physiol 2005; 288:F785-F791.
69. Eckert RE, Karsten AJ, Utz J, Ziegler M. Regulation of renal artery smooth muscle tone by alphal -adrenoceptors: role of voltage-gated calcium channels and intracellular calcium stores. Urol Res 2000; 28:122-127.
70. Hordijk PL. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 2006; 98:453-462.
71. •• Just A, Olson AJ, Whitten CL, Arendshorst WJ. Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am J Physiol Heart Circ Physiol 2007; 292:H83-H92. Research showing a significant functional role of NAD(P)H oxidase activity in mediating renal vasoconstriction induced acutely by Ang II, norepinephrine and phenylephrine in anesthetized rats by an apparent direct action of superoxide anion on arteriolar VSMC independent of NO quenching.
72. Just A, Whitten CL, Arendshorst WJ. Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA- and ETB-receptors. Am J Physiol - Renal Physiol 2008; 294:F719-F728.
73. Zhang AY, Yi F, Teggatz EG, et al. Enhanced production and action of cyclic ADP-ribose during oxidative stress in small bovine coronary arterial smooth muscle. Microvasc Res 2004; 67:159-167.
74. Hua H, Munk S, Goldberg H, et al. High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. J Biol Chem 2003; 278:33951-33962.
75. Ma R, Du J, Sours S, Ding M. Store-operated Ca2+ channel in renal microcirculation and glomeruli. Exp Biol Med (Maywood) 2006; 231:145-153.
76. Feng Z, Wei C, Chen X, et al. Essential role of Ca2+ release channels in angiotensin ll-induced Ca2+ oscillations and mesangial cell contraction. Kidney Int 2006; 70:130-138.
77. Nam TS, Choi SH, Rah SY, et al. Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase: Implication for intracellular calcium signal mediated by cyclic ADP-ribose. Exp Mol Med 2006; 38:718-726.
78. Facemire CS, Arendshorst WJ. Calmodulin mediates norepinephrine-induced receptor-operated calcium entry in preglomerular resistance arteries. Am J Physiol Renal Physiol 2005; 289:F127-F136.
79. Salomonsson M, Brannstrom K, Arendshorst WJ. a, -Adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies. Am J Physiol Renal Physiol 2000; 278:F138-F147.
80. • Yi F, Zhang AY, Li N, et al. Role of cyclic ADP-ribose-Ca2+ signaling in mediating renin production and release in As4.1 cells. Cell Physiol Biochem 2007; 19:293-302. This is the first study linking ADPR cyclase to renin production, using cultured clonal As4.1 cells as a model of juxtaglomerular granular cells.
81. Lisy O, Burnett JC Jr. New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancing. Circulation 2006; 113:246-251.
82. B receptor induced renal vasoconstriction in anesthetized rats.
83. Cooper CL, Malik KU. Contribution of Ca++ and calmodulin to the action of norepinephrine on renal prostaglandin synthesis and vascular tone. J Pharmacol Exp Ther 1986; 236:424-431.
84. Cooper CL, Shaffer JE, Malik KU. Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of Ca++ antagonists and calmodulin inhibitors. Orc Res 1985;56:97-108.
85. Cooper CL, Malik KU. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors. J Pharmacol Exp Ther 1984; 229:139-147.
86. Zhang G, Teggatz EG, Zhang AY, et al. Cyclic ADP ribose-mediated Ca2+ signaling in mediating endothelial nitric oxide production in bovine coronary arteries. Am J Physiol Heart Circ Physiol 2006; 290:H1172-H1181.
87. •• Satriano J, Cunard R, Peterson OW, et al. Effects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generation. Am J Physiol Renal Physiol 2008; 294:F795-F800. Novel observations link ADPR cyclase and RyR to NO production and the resultant endothelium-dependent renal vasodilatation in vivo.
88. Ma MC, Huang HS, Wu MS, et al. Impaired renal sensory responses after renal ischemia in the rat. J Am Soc Nephrol 2002; 13:1872-1883.
89. Thai TL, Arendshorst WJ. Phenotypic characterization of acute systemic and renal vascular responses to angiotensin II, norepinephrine, and endothelin-1 in mice lacking the ADP ribosyl cyclase CD38 (Abstract). FASEB J 2008; 22:x.
90. Long C, Cook LG, Wu GY, Mitchell BM. Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction. Arterioscler Thromb Vase Biol 2007; 27:1580-1586.
91. Eu JP, Xu L, Stamler JS, Meissner G. Regulation of ryanodine receptors by reactive nitrogen species. Biochem Pharmacol 1999; 57:1079-1084.
92. Li N, Zou AP, Ge ZD, et al. Effect of nitric oxide on calcium-induced calcium release in coronary arterial smooth muscle. Gen Pharmacol 2000; 35:37-45.
93. Yu JZ, Zhang DX, Zou AP, et al. Nitric oxide inhibits Ca(2+) mobilization through cADP-ribose signaling in coronary arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 2000; 279:H873-H881.
94. Pauvert O, Marthan R, Savineau J. NO-induced modulation of calciumoscillations in pulmonary vascular smooth muscle. Cell Calcium 2000; 27:329-338.
95. Kannan MS, Prakash YS, Johnson DE, Sieck GC. Nitric oxide inhibits calcium release from sarcoplasmic reticulum of porcine tracheal smooth muscle cells. Am J Physiol 1997; 272:L1-L7.
96. White TA, Walseth TF, Kannan MS. Nitric oxide inhibits ADP-ribosyl cyclase through a cGMP-independent pathway in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002; 283:L1065-L1071.
97. Ji J, Benishin CG, Pang PK. Nitric oxide selectively inhibits intracellular Ca++ release elicited by inositol trisphosphate but not caffeine in rat vascular smooth muscle. J Pharmacol Exper Therap 1998; 285:16-21.
98. Mandala M, Heppner TJ, Bonev AD, Nelson MT. Effect of endogenous and exogenous nitric oxide on calcium sparks as targets for vasodilation in rat cerebral artery. Nitric Oxide 2007; 16:104-109.
99. Lehnart SE, Mongillo M, Bellinger A, et al. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest 2008; 118:2230-2245.
100. Tiso N, Bauce B, Rampazzo A, et al. Gene symbol: RYR2. Disease: Arrhythmogenic right ventricular cardiomyopathy type 2. Hum Genet 2004; 114:405.
101. Barbosa MT, Soares SM, Novak CM, et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of dietinduced obesity. FASEB J 2007; 21:3629-3639.
102. Johnson JD, Ford EL, Bemal-Mizrachi E, et al. Suppressed insulin signaling and increased apoptosis in CD38-null islets. Diabetes 2006; 55:2737-2746.
103. Takahashi J, Kagaya Y, Kato I, et al. Deficit of CD38/cyclic ADP-ribose is differentially compensated in hearts by gender. Biochem Biophys Res Commun 2003; 312:434-440.
104. Kato I, Yamamoto Y, Fujimura M, et al. CD38 disruption impairs glucoseinduced increases in cyclic ADP-ribose, [Ca2+]i, and insulin secretion. J Biol Chem 1999; 274:1869-1872.
105. Pupilli C, Antoneili A, lughetti L, et al. Anti-CD38 autoimmunity in children with newly diagnosed type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2005; 18:1417-1423.
106. Skeie GO, Romi F, Aarli JA, et al. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Ann N Y Acad Sci 2003; 998:343-350.
107. Kinnear NP, Boittin FX, Thomas JM, et al. Lysosome-sarcoplasmic reticulum junctions. A trigger zone for calcium signaling by nicotinic acid adenine dinucleotide phosphate and endothelin-1. J Biol Chem 2004; 279:54319-54326.
108. Takeshima H, YamazawaT, Ikemoto T, et al. Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. EMBO J 1995; 14:2999-3006.
109. Clancy JS, Takeshima H, Hamilton SL, Reid MB. Contractile function is unaltered in diaphragm from mice lacking calcium release channel isoform 3. Am J Physiol 1999; 277:R1205-R1209.
110. Shou W, Aghdasi B, Armstrong DL, et al. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 1998; 391:489-492.
111. Xin HB, Senbonmatsu T, Cheng DS, et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002; 416:334-338.
112. Dumont FJ. FK506 an immunosuppressant targeting calcineurin function. Curr Med Chem 2000; 7:731-748.
113. Hill-Eubanks DC, Gomez MF, Stevenson AS, Nelson MT. NFAT regulation in smooth muscle. Trends Cardiovasc Med 2003; 13:56-62.
114. Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 2008; 22:1-15.
115. Agirbasli M, Papila-Topal N, Ogutmen B, et al. The blockade of the reninangiotensin system reverses tacrolimus related cardiovascular toxicity at the histopathological level. J Renin Angiotensin Aldosterone Syst 2007; 8:54-58.
116. Finn WF. FK506 nephrotoxicity. Ren Fail 1999; 21:319-329.
117. Lindenfeld J, Miller GG.ShakarSF, et al. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation 2004; 110:3858-3865.
118. Takeda Y, Miyamori I, Furukawa K, et al. Mechanisms of FK 506-induced hypertension in the rat. Hypertension 1999; 33:130-136.
119. Long C, Cook LG, Hamilton SL, et al. FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension 2007; 49:569-576.